Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Primers used for analysis of four SNPs in one gene. by Winnie Okore (14139712)

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Data Sheet 1_Development of an LC-MS/MS method for astaxanthin quantification in shrimp tissues and its application to detect astaxanthin variations during ovary development stages... by Shuo Diao (1967698)

“…</p>Methods<p>The separation was performed on a BEH C8 column (1.7 μm, 2.1 × 50 mm) using a a gradient elution. …”

Multiple homologs of 16p12.1 genes contribute to neurodevelopmental defects in <i>Drosophila melanogaster</i> and <i>X</i>. <i>laevis</i>. by Lucilla Pizzo (2735491)

“…<i>laevis</i> represents controls injected with the highest amount of morpholino (50 ng, see <b><a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009112#pgen.1009112.s005" target="_blank">S5 Fig</a></b>). …”

I-R-Polar-Negative-0902 by Sheng-Yuan Ho (16909464)

“…As the lockmass, we utilized leucine-enkephalin (m/z = 556.2771) at a concentration of 1 ng/L and a flow rate of 5 L/min. …”

Possible roles of sestrin2 in multiple sclerosis and its relationships with clinical outcomes by Faruk Omer ODABAS (12652740)

“…Conclusions: The decreased expression of SESN2 may play a role in MS pathogenesis, and SESN2 could be used as a biomarker for MS and as immunotherapeutic agent to treat MS.…”

Data_Sheet_1_Dynamic Changes of Endogenic or Exogenic β-Carboline Alkaloid Harmine in Different Mammals and Human in vivo at Developmental and Physiological States.pdf by Ning Cao (158319)

Purification and characterization of the deletion mutants. by Amanda Jack (11547638)

“…<b>(C)</b> EMSA gels using no RNA, 10 nM 0–5 kb viral RNA, or 50 ng/μL polyC RNA and decreasing concentration of the ΔR2 mutant. …”